Related Experiment Videos
Signal relays in the VEGF system
N Ortega1, H Hutchings, J Plouët
1Laboratoire de Biologie Moleculaire Eucaryote, CNRS UPR 9006, 118 Route de Narbonne, 31062 Toulouse cedex, France.
Frontiers in Bioscience : a Journal and Virtual Library
|January 30, 1999
Summary
Vascular Endothelial Growth Factor (VEGF) drives angiogenesis, with different isoforms and receptors (VEGFR1, VEGFR2) mediating distinct cell responses like migration and proliferation. Understanding VEGF signaling advances new drug development for angiogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for development and disease.
- Vascular Endothelial Growth Factor (VEGF) is identified as a primary regulator of angiogenesis.
- VEGF exhibits diverse isoforms due to alternative splicing, impacting its function and interactions.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying VEGF-mediated angiogenesis.
- To understand the distinct roles of VEGF receptors (VEGFR1, VEGFR2) and neuropilin-1 in endothelial cell signaling.
- To identify factors required for endothelial cell activation and angiogenic potential.
Main Methods:
- Investigated VEGF isoforms and their interactions with receptors VEGFR1, VEGFR2, and neuropilin-1.
- Analyzed signal transduction pathways downstream of VEGF receptor activation.
- Utilized anti-idiotypic antibody strategies to generate internal images of VEGF and study endothelial cell responses.
Main Results:
- VEGF isoforms display differential extracellular matrix binding and signaling.
- VEGFR1 activation is linked to endothelial cell migration, while VEGFR2 activation promotes cell proliferation.
- Quiescent endothelial cells require activation by specific factors to respond to mitogenic signals and develop an angiogenic phenotype.
Conclusions:
- The VEGF system, comprising various isoforms and receptors, plays a central role in regulating angiogenesis.
- Distinct signaling pathways of VEGFR1 and VEGFR2 govern specific endothelial cell behaviors.
- Targeting the VEGF pathway holds promise for developing novel therapeutic agents for angiogenesis-related conditions.